Covered recipient · General Payments record
LORI J RAINEY
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$873.55
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $302.96 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exeltis, USA Inc. | $92.19 | 5 |
| Sage Therapeutics, Inc. | $63.36 | 3 |
| Organon LLC | $34.36 | 3 |
| PFIZER INC. | $21.77 | 1 |
| Novo Nordisk AS | $21.08 | 1 |
| Hologic Sales and Service, LLC | $20.52 | 1 |
| ConvaTec Inc. | $16.93 | 1 |
| Astellas Pharma US Inc | $16.68 | 1 |
| Sumitomo Pharma America, Inc. | $16.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $16.68 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139519785 | CMS |
| ConvaTec Inc. | $16.93 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151393145 | CMS |
| Exeltis, USA Inc. | $20.58 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150018375 | CMS |
| Exeltis, USA Inc. | $20.07 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150018377 | CMS |
| Exeltis, USA Inc. | $17.02 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150018379 | CMS |
| Exeltis, USA Inc. | $13.72 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150018381 | CMS |
| Exeltis, USA Inc. | $20.80 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150018383 | CMS |
| Hologic Sales and Service, LLC | $20.52 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084884233 | CMS |
| Novo Nordisk Inc | $21.08 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100377939 | CMS |
| Organon Llc | $14.40 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136288788 | CMS |
| Organon Llc | $19.20 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136288792 | CMS |
| Organon Llc | $0.76 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136288796 | CMS |
| PFIZER INC. | $21.77 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130998972 | CMS |
| Sage Therapeutics, Inc. | $23.20 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120399716 | CMS |
| Sage Therapeutics, Inc. | $14.93 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120406212 | CMS |
| Sage Therapeutics, Inc. | $25.23 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120394888 | CMS |
| Sumitomo Pharma America, Inc. | $16.07 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148989528 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.